Navigation Links
Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
Date:1/7/2008

CHESHIRE, Conn., Jan. 7 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (the "Company," Nasdaq: ALXN) today announced that it has commenced dosing in the AEGIS study, a single registration study to evaluate the safety, efficacy, and pharmacology of Soliris(R) (eculizumab) as a treatment for Japanese patients with paroxysmal nocturnal hemoglobinuria (PNH). When fully enrolled, the open-label study, authorized by Japan's Pharmaceutical and Medical Device Administration (PMDA), is expected to include approximately 25 patients with PNH at clinical sites throughout Japan. Each PNH patient in the AEGIS study will be dosed with Soliris for 12 weeks after enrollment.

PNH is a rare acquired genetic blood disorder defined by hemolysis, in which patients' red blood cells are destroyed by complement, a component of the body's immune system. The primary efficacy endpoint of the study is reduction of hemolysis from baseline. The study will also measure the effect of Soliris on other clinical manifestations of PNH, including blood transfusion requirements, thromboses (blood clots), and kidney function. Patients' overall quality of life, including fatigue, will also be assessed.

The inclusion and exclusion criteria for the AEGIS study are similar to those used in one of Alexion's previous Phase 3 studies of Soliris as a treatment for PNH, the SHEPHERD study. SHEPHERD examined the safety and efficacy of eculizumab in a broad and diverse population of patients with PNH, including enrollment of patients with minimal transfusion requirements and/or evidence of thrombocytopenia. (1) Based on the SHEPHERD study and the TRIUMPH Phase 3 study, (2) Soliris was approved as the first treatment for patients with PNH by the U.S. Food and Drug Administration in March 2007 and by the European Commission in June 2007.

"Commencing patient dosing with eculizumab in the Japanese registration study represents an important step toward providing patients with PNH in J
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
2. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
3. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
4. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
5. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
6. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
10. MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule
11. VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... JORDAN, Utah , July 10, 2014  BC ... solutions, and MiE America , Inc., a leading ... have entered into a long-term agreement naming BC Technical ... the US. MiE and BC Technical ... strategic agreement to establish BC Technical as the service ...
(Date:7/10/2014)... 10, 2014   LabStyle Innovations Corp . ... announced the appointment of Professor Richard B. ... Board of Directors. Prof. Stone brings ... to LabStyle as an entrepreneur, venture capitalist public, ... governance expert. He currently serves on the board ...
(Date:1/15/2014)... 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) ... support, China,s orthopedic instrument industry ... market size rising from 3.28 billion yuan in 2006 ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3
... Sept. 7 According to Millennium Research Group (MRG), ... in Japan,s Ministry of Health Labour and Welfare (MHLW) ... catheters, will lead to double-digit growth in this segment ... market revenues. Unlike in the US ...
... Reportlinker.com announces that a new market research ... Drug Delivery in Central Nervous System Diseases ... http://www.reportlinker.com/p0203542/Drug-Delivery-in-Central-Nervous-System-Diseases---technologiesmarkets-and-companies.html SummaryThe delivery ... a challenge in the treatment of neurological disorders. ...
Cached Medicine Technology:Will MHLW Changes in Reimbursement Drive Japanese Physicians to Increase Usage of Chronic Dialysis Catheters? 2Will MHLW Changes in Reimbursement Drive Japanese Physicians to Increase Usage of Chronic Dialysis Catheters? 3Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 2Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 3Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 4Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 5Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 6Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 7Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 8Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 9Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 10Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 11Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 12Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 13Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 14Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 15Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 16Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies 17
(Date:7/12/2014)... HealthDay Reporter SATURDAY, July ... that a surgical technique used to grind up uterine growths ... of spreading cancer to other parts of a woman,s body, ... the Food and Drug Administration also said that women who ... should sign a written consent stating that they understand the ...
(Date:7/12/2014)... The fastest-growing mobile technology is LTE ... of LTE networks continues to grow due to the ... have increased mobile data traffic, which is a major ... Communications Test and Measurement equipment comply with industry standards, ... Test and Measurement Market is estimated to grown from ...
(Date:7/12/2014)... PA (PRWEB) July 12, 2014 "The second ... it’s uncomfortable and painful to wear shoes," said an inventor ... special sock that prevents this from happening. , He then ... effective way to prevent the second and big toes from ... endurance while wearing shoes. Ergonomic and easy to use, it's ...
(Date:7/12/2014)... With prom shopping reaching its final days, ... ready to showcase its new and trendy apparels. Recently, ... dresses in its online shop. Additionally, it is now ... elegant gowns. According to the company’s sales manager, the ... 2014. , He says, “Now, worldwide clients can ...
(Date:7/12/2014)... York, NY (PRWEB) July 12, 2014 As ... (the National Institute of Standards and Technology), the June 25th, ... the electronic discovery world. It was also ... finally in, depending on whether it was seen from an ... But this much is fact, there is now precedent which ...
Breaking Medicine News(10 mins):Health News:FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids 2Health News:FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids 3Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 5Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 2Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 3Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 4Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 5
... is deeply disturbed that the Food and Drug ... vulnerable populations such as women of child-bearing age, ... recommendation flies in the face of decades of ... of mercury from food, especially on the developing ...
... Univita Health will provide an integrated approach to home-based care and ... 15 The launch of a new company aimed at promoting ... Univita Health is introducing new programs and innovating existing services to ... , "Due to falling birthrates and increased ...
... per cent of the men who took part in the ... trial were diagnosed with the disease and the majority of ... published in the December issue of the urology journal ... women aged from 55 to 74 took part in the ...
... Dec. 15 Today, a parent of a mercury-poisoning victim joined ... proposal to stop warning pregnant women and children about exposure risks ... "We,ve known for years that mercury is toxic to ... individual,s status. For FDA to suddenly change the equation to ...
... hair loss for,both men and women is a very traumatic ... help our clients that worked unlike many potions,lotions and product ... it is the only true hair regeneration laser on the ... Medical, Northwestern,University , Mass General, etc.). They are ...
... 15 Greenway Medical Technologies,Inc. today announced that ... (EHR) solution, PrimeSuite(R), won,three "Best in KLAS" awards ... KLAS Awards,report. For the third consecutive year, ... ambulatory EMR category for practices having between six ...
Cached Medicine News:Health News:CU Statement on FDA Position on Mercury From Fish Consumption 2Health News:Launch of New 'Independent Aging' Company Will Address the Needs of the Growing Senior Population 2Health News:Launch of New 'Independent Aging' Company Will Address the Needs of the Growing Senior Population 3Health News:USA's largest ever prostate cancer screening program shows high compliance and consistent results 2Health News:USA's largest ever prostate cancer screening program shows high compliance and consistent results 3Health News:FDA's Proposed Mercury Fish Advice Based on Flawed Science, Say MD and Anti-Mercury Advocates 2Health News:Greenway Medical Technologies' EHR Solution, PrimeSuite, Wins Three 'Best in KLAS' Awards 2Health News:Greenway Medical Technologies' EHR Solution, PrimeSuite, Wins Three 'Best in KLAS' Awards 3Health News:Greenway Medical Technologies' EHR Solution, PrimeSuite, Wins Three 'Best in KLAS' Awards 4
... Pro Osteon Bone Graft Substitutes a natural ... from cadaver bone, but such grafts may ... disease transmission. Interpore Cross has developed the ... to address these needs, offering surgeons a ...
... Healos is an osteoconductive matrix constructed ... fully coated with hydroxyapatite through a ... with autogenous bone marrow aspirate, Healos ... cell attachment, proliferation and differentiation. The ...
Weitlaner-Locktite retractors, blunt, 11 cm total length....
Sharp Weitlaner Retractor....
Medicine Products: